Niva Bupa Q2 Profit Jumps 124% as Premiums Grow 35%

Niva Bupa Health Insurance Company, one of India's standalone health insurers, announced its results for the quarter and half year ended September 30, 2026 on November 4, 2026. The company's board approved the unaudited results that day. This article reports the figures from the company's press release filed with the National Stock Exchange and from published coverage of the detailed results, and it identifies which source each number comes from, because the press release and the coverage report different measures in a few places.

Profit and premium

Profit after tax for the quarter was about ₹136 crore. Coverage of the detailed filing gives the exact figure as ₹135.64 crore, compared with ₹60.52 crore in the same quarter of the previous financial year. That is an increase of about 124%, which matches the company's own description. Profit before tax was ₹181.53 crore, against ₹81.74 crore. One crore is ten million, so ₹136 crore is about 1.36 billion rupees.

Gross written premium, the total premium booked before reinsurance, was ₹2,484 crore, up 35% from about ₹1,843 crore. For the first half of the year, published coverage reports gross written premium of ₹4,634 crore, up 33.4%. Insurance revenue, which is the premium recognized as earned under the Indian Accounting Standards that the company adopted from April 2026, was ₹2,412.27 crore against ₹1,899.07 crore, an increase of about 27%, calculated here. The insurance service result, the profit from insurance contracts before investment income, rose to ₹125.99 crore from ₹45.54 crore.

Retail health, the segment in which individuals and families buy their own policies, grew faster than the total. The press release states retail health gross written premium was ₹1,876 crore, up 47%, and that the company's market share in retail health was 11% at the end of the first half.

Claims, expenses and margins

The claims ratio, claims as a share of insurance revenue, improved to 63.09% from 65.08%. The expense ratio fell to 30.10% from 31.53%. Together they give a combined operating ratio of 93.20%, compared with 96.62% a year earlier, an improvement of about 3.4 percentage points, calculated here. A ratio below 100% means the insurer's claims and costs were less than the premium revenue it recognized in the period. The insurance service margin was 6.80%, against 3.38%, and the net insurance margin was 11.84%, against 10.27%.

The coverage reports two return measures that are not directly comparable. A quarterly return on equity of 3.53%, against 1.75%, appears in the detailed results. The press release gives an annualized return on average net worth of 14.7% for the first half, against 7.8% a year earlier. The second figure is annualized and the first is not, which explains most of the difference in appearance.

Claims service

The press release gives a number of operating indicators. The claim settlement ratio for the first half of the financial year was 95.6%, compared with 94.4% for the full previous year. More than 90% of cashless claims were processed in under 30 minutes, and more than 39% of claims were auto-adjudicated using artificial intelligence, meaning a system approved them without manual review. The company reports a weighted episodal net promoter score of 63, up six points, and a cashless discharge score of 74, up ten points, based on feedback from more than 1.9 lakh customers.

These are company-reported measures. Net promoter scores and settlement ratios are not audited and are defined by each insurer, so they are best used to compare a company with its own earlier periods.

Distribution and scale

Individual agents were the largest sales channel, at 34% of gross written premium in the quarter, while the direct channel was the fastest growing, up 46%. As of September 30, 2026, the company's distribution network included about 2.7 lakh agents, more than 620 brokers, and more than 135 bancassurance and other corporate agency partners, plus over 225 physical branches. The hospital and provider network exceeded 16,000. The company said it serves close to 27 million lives and has about 11,200 employees.

Vishwanath Mahendra, the company's executive director and chief financial officer, said the focus remains on pursuing profitable growth while continuing to improve operating efficiencies, according to the press release.

Solvency and the regulatory order

Coverage of the detailed results reports a solvency ratio of 2.03 against 2.85 a year earlier. The solvency ratio compares an insurer's available capital with the capital its regulator requires, and the Insurance Regulatory and Development Authority of India sets a minimum of 1.5. A ratio of 2.03 is comfortably above the minimum, but the decline over the year shows that fast premium growth uses up capital. The press release itself reports a different measure, a combined insurance solvency ratio of 98.8%, which is not described further and should not be compared with the 2.03 figure.

The same coverage says the regulator ordered the company not to open new places of business for six months over limits on expenses of management in the 2024-25 financial year, and that the company accepted the order and will not appeal. It also says the company reported compliance with the expenses-of-management limits for the second quarter and the first half of 2026-27. The press release does not mention the order, so readers should check the company's stock exchange filings for the original wording.

Market reaction

Shares closed at ₹78.19 on the NSE on November 4, up 6.6% on the day, according to coverage of the results. The time stamp on the exchange filing suggests the results were filed in the evening India time, after that day's close, so the November 4 move should not be read as a reaction to them. A share price is in any case not a measure of the quality of a quarter.

What to watch

Three questions follow from the quarter. Can the company keep premium growth in the mid-thirties while holding the combined operating ratio below 95%? How will the solvency ratio move as growth continues and whether the company needs to raise capital? And how will the restriction on new places of business affect branch-led growth, given that agents and the direct channel already account for a large share of sales? The next set of quarterly results will show whether the improvement in margins is lasting.

Sources: Niva Bupa Health Insurance Company's press release on Q2 and H1 FY27 results, filed with the National Stock Exchange of India on November 4, 2026, and published coverage of the detailed results by Kotak Neo and Investywise. Growth rates labelled as calculated here are derived from the reported figures.